Novonesis (novozymes)-ADRNVZMY
13F holders, Q3 2024 (September 30)9holders +3
2new positions
0sold out
$72.07avg. 13F price*
At the end of Q3 2024, 9 institutions reported holding Novonesis (novozymes)-ADR (NVZMY) in their 13F filings, up 3 from Q2 2024. 2 opened new positions and 0 sold out. The largest holders were Rhumbline Advisers ($733K), Sterling Capital Management LLC ($525K) and S&co Inc. ($324K).
- Company
- Novonesis (novozymes)-ADR
- Filed as
- NOVOZYMES A/S-UNSPONS ADR (Q3 2024)
- CUSIP
- 670108109
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $8K |
| Exits | 0 | $0 |
All 13F filers, Q2 2024 → Q3 2024: 2,032 shares bought and 5,608 shares sold, net −3,576 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 9 holders
| Rhumbline Advisers | 0.00% | Add +17.9% | 10,176 | $733K |
| Sterling Capital Management LLC | 0.01% | — | 7,266 | $525K |
| S&co Inc. | 0.02% | No change | 4,500 | $324K |
| Boston Common Asset Management, LLC | 0.01% | Reduce -10.7% | 4,119 | $297K |
| PNC Financial Services Group, Inc. | 0.00% | Reduce -8.1% | 1,942 | $140K |
| GAMMA Investing LLC | 0.01% | Add +49.7% | 1,121 | $81K |
| Mar Vista Investment Partners LLC | 0.00% | Reduce -87.0% | 737 | $53K |
| Eagle Bay Advisors LLC | 0.00% | New | 71 | $5K |
| Copeland Capital Management, LLC | 0.00% | New | 45 | $3K |
"% of holder's portfolio" is NVZMY's weight in each manager's 13F, not the share of Novonesis (novozymes)-ADR the manager owns.